Summary
Can dietitian-led intensive telehealth support to maximise nutritional intake through dietary strategies, symptom management and the option for 'top-up' small bowel tube feeding improve quality of life in people with pancreatic cancer?
You may be eligible for this study if you have a new primary diagnosis of borderline resectable, locally advanced, metastatic or inoperable pancreatic cancer and are commencing chemotherapy.
Eligible participants will be randomly (by chance) allocated to one of two groups:
- usual care or
- intensive dietetics intervention (counselling, education, symptom management, oral nutrition support, with or without jejunal tube feeding if the participating chooses) delivered via telehealth.
For those randomised to the intervention group, participants will receive the active intervention for 6 months, beginning as soon as possible after diagnosis. Personalised nutrition support and/or advice will be provided. Outcomes will be measured at baseline and at follow up at 3 and 6 months.
It is hoped this study will demonstrate the effectiveness of early and frequent dietetic intervention and supplemental jejunal feeding (when required), in enhancing quality of life.
Conditions
This trial is treating people with newly diagnosed, borderline resectable, locally advanced, or metastatic pancreatic cancer who are commencing chemotherapy